(Q42818142)

English

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.

scientific article published on June 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

7 November 2017

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen. (English)

1 reference

stated in

Europe PubMed Central

7 November 2017

0 references

multiple drug resistance

1 reference

Scudiero DA

1

1 reference

stated in

Europe PubMed Central

PubMed ID

9625176

retrieved

7 November 2017

Monks A

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

9625176

retrieved

7 November 2017

Sausville EA

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

9625176

retrieved

7 November 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

stated in

Europe PubMed Central

7 November 2017

Journal of the National Cancer Institute

1 reference

stated in

Europe PubMed Central

7 November 2017

90

1 reference

stated in

Europe PubMed Central

7 November 2017

862

1 reference

stated in

Europe PubMed Central

7 November 2017

11

1 reference

stated in

Europe PubMed Central

PubMed ID

9625176

retrieved

7 November 2017

describes a project that uses

NCI-ADR-RES

0 references

Identifiers

DOI

10.1093/JNCI/90.11.862

1 reference

stated in

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

PubMed ID

9625176

retrieved

7 November 2017

ResearchGate publication ID

13659696

0 references

(Q42818142)

Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)